BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 34933066)

  • 1. Twice-Weekly Hemodialysis With Adjuvant Pharmacotherapy and Transition to Thrice-Weekly Hemodialysis: A Pilot Study.
    Murea M; Patel A; Highland BR; Yang W; Fletcher AJ; Kalantar-Zadeh K; Dressler E; Russell GB
    Am J Kidney Dis; 2022 Aug; 80(2):227-240.e1. PubMed ID: 34933066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-reported outcomes in a pilot clinical trial of twice-weekly hemodialysis start with adjuvant pharmacotherapy and transition to thrice-weekly hemodialysis vs conventional hemodialysis.
    Murea M; Highland BR; Yang W; Dressler E; Russell GB
    BMC Nephrol; 2022 Sep; 23(1):322. PubMed ID: 36167537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal replacement treatment initiation with twice-weekly versus thrice-weekly haemodialysis in patients with incident dialysis-dependent kidney disease: rationale and design of the TWOPLUS pilot clinical trial.
    Murea M; Moossavi S; Fletcher AJ; Jones DN; Sheikh HI; Russell G; Kalantar-Zadeh K
    BMJ Open; 2021 May; 11(5):e047596. PubMed ID: 34031117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incremental Hemodialysis, Residual Kidney Function, and Mortality Risk in Incident Dialysis Patients: A Cohort Study.
    Obi Y; Streja E; Rhee CM; Ravel V; Amin AN; Cupisti A; Chen J; Mathew AT; Kovesdy CP; Mehrotra R; Kalantar-Zadeh K
    Am J Kidney Dis; 2016 Aug; 68(2):256-265. PubMed ID: 26867814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twice-weekly and incremental hemodialysis treatment for initiation of kidney replacement therapy.
    Kalantar-Zadeh K; Unruh M; Zager PG; Kovesdy CP; Bargman JM; Chen J; Sankarasubbaiyan S; Shah G; Golper T; Sherman RA; Goldfarb DS
    Am J Kidney Dis; 2014 Aug; 64(2):181-6. PubMed ID: 24840669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IHDIP: a controlled randomized trial to assess the security and effectiveness of the incremental hemodialysis in incident patients.
    Deira J; Suárez MA; López F; García-Cabrera E; Gascón A; Torregrosa E; García GE; Huertas J; de la Flor JC; Puello S; Gómez-Raja J; Grande J; Lerma JL; Corradino C; Musso C; Ramos M; Martín J; Basile C; Casino FG
    BMC Nephrol; 2019 Jan; 20(1):8. PubMed ID: 30626347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incremental Hemodialysis: The University of California Irvine Experience.
    Ghahremani-Ghajar M; Rojas-Bautista V; Lau WL; Pahl M; Hernandez M; Jin A; Reddy U; Chou J; Obi Y; Kalantar-Zadeh K; Rhee CM
    Semin Dial; 2017 May; 30(3):262-269. PubMed ID: 28295607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter feasibility randomized controlled trial to assess the impact of incremental versus conventional initiation of hemodialysis on residual kidney function.
    Vilar E; Kaja Kamal RM; Fotheringham J; Busby A; Berdeprado J; Kislowska E; Wellsted D; Alchi B; Burton JO; Davenport A; Farrington K
    Kidney Int; 2022 Mar; 101(3):615-625. PubMed ID: 34418414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of incremental versus conventional initiation of haemodialysis on residual kidney function: study protocol for a multicentre feasibility randomised controlled trial.
    Kaja Kamal RM; Farrington K; Wellsted D; Sridharan S; Alchi B; Burton J; Davenport A; Vilar E
    BMJ Open; 2020 Aug; 10(8):e035919. PubMed ID: 32792431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of initial twice-weekly hemodialysis treatment with preservation of residual kidney function in ESRD patients.
    Zhang M; Wang M; Li H; Yu P; Yuan L; Hao C; Chen J; Kalantar-Zadeh K
    Am J Nephrol; 2014; 40(2):140-50. PubMed ID: 25171342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of outcomes between the incremental and thrice-weekly initiation of hemodialysis: a propensity-matched study of a prospective cohort in Korea.
    Park JI; Park JT; Kim YL; Kang SW; Yang CW; Kim NH; Oh YK; Lim CS; Kim YS; Lee JP;
    Nephrol Dial Transplant; 2017 Feb; 32(2):355-363. PubMed ID: 28186541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrafiltration Rate, Residual Kidney Function, and Survival Among Patients Treated With Reduced-Frequency Hemodialysis.
    Lee YJ; Okuda Y; Sy J; Lee YK; Obi Y; Cho S; Chen JLT; Jin A; Rhee CM; Kalantar-Zadeh K; Streja E
    Am J Kidney Dis; 2020 Mar; 75(3):342-350. PubMed ID: 31813665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of residual renal function in patients undergoing twice-weekly versus three-times-weekly haemodialysis.
    Lin YF; Huang JW; Wu MS; Chu TS; Lin SL; Chen YM; Tsai TJ; Wu KD
    Nephrology (Carlton); 2009 Feb; 14(1):59-64. PubMed ID: 19019171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initiating renal replacement therapy through incremental haemodialysis: Protocol for a randomized multicentre clinical trial.
    Fernández Lucas M; Ruíz-Roso G; Merino JL; Sánchez R; Bouarich H; Herrero JA; Muriel A; Zamora J; Collado A
    Trials; 2020 Feb; 21(1):206. PubMed ID: 32075665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Clinical Outcome Between Twice-Weekly and Thrice-Weekly Hemodialysis in Patients With Residual Kidney Function.
    Hwang HS; Hong YA; Yoon HE; Chang YK; Kim SY; Kim YO; Jin DC; Kim SH; Kim YL; Kim YS; Kang SW; Kim NH; Yang CW
    Medicine (Baltimore); 2016 Feb; 95(7):e2767. PubMed ID: 26886622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic and Laboratory Changes during Incremental Transition from Twice to Thrice-Weekly Hemodialysis.
    Hur I; Wenziger C; Obi Y; Moradi H; Streja E; Tantisattamo E; Choi SJ; Lau WL; Chang Y; Jin A; Chen JLT; Kovesdy CP; Rhee CM; Kalantar-Zadeh K
    Cardiorenal Med; 2020; 10(2):97-107. PubMed ID: 31935740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal trends in fluid management with incremental hemodialysis
.
    Bowline IG; Russell GB; Bagwell B; Crossley B; Fletcher AJ; Murea M
    Clin Nephrol; 2019 Oct; 92(4):165-173. PubMed ID: 31347496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incremental Hemodialysis: What We Know so Far.
    Soi V; Faber MD; Paul R
    Int J Nephrol Renovasc Dis; 2022; 15():161-172. PubMed ID: 35520631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of Incremental 2-Times Weekly Hemodialysis in Incident Patients With Residual Kidney Function.
    Chin AI; Appasamy S; Carey RJ; Madan N
    Kidney Int Rep; 2017 Sep; 2(5):933-942. PubMed ID: 29270499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between incremental and thrice-weekly haemodialysis: Systematic review and meta-analysis.
    Liu Y; Zou W; Wu J; Liu L; He Q
    Nephrology (Carlton); 2019 Apr; 24(4):438-444. PubMed ID: 29532551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.